Genetically engineered microglia-like cells have therapeutic potential for neurodegenerative disease
Robert N. Plasschaert(ProterixBio (United States)), Chris Mason(Oak Ridge National Laboratory), Quoc Nguyen(ProterixBio (United States)), Zeenath Unnisa(ProterixBio (United States)), Fritz Hull(ProterixBio (United States)), Jeffrey W. Schindler(Forma Therapeutics (United States)), Luigi Barbarossa(ProterixBio (United States)), Niek P. van Til(Amsterdam Neuroscience), Tara Peterson(ProterixBio (United States)), Mariana Loperfido(ProterixBio (United States)), John K. Yoon(ProterixBio (United States)), Cristina Baricordi(Broad Institute), Mark P. DeAndrade(ProterixBio (United States)), Aimin Yan(ProterixBio (United States)), Luca Biasco(Institute of Infection and Immunity), Yildirim Dogan(Memorial Sloan Kettering Cancer Center)
Cited by 2
Related Papers
A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
Highly efficient therapeutic gene editing of human hematopoietic stem cells
|Nature Medicine|2019|518
BTRFS
|ACM Transactions on Storage|2013|381
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276